Ibrutinib in combination with low-dose dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: results from a multicenter phase 2 trial
| Autor: | Richardson, P.G., Bensinger, W.I., Huff, C.A., Costello, C.L., Lendvai, N., Berdeja, J.G., Anderson, L.D., Siegel, D.S., Jagannath, S., Laubach, J.P., Stockerl-Goldstein, K.E., Knapp, L., Kwei, L., Clow, F., Graef, T., Bilotti, E., Vij, R. |
|---|---|
| Zdroj: | In Clinical Lymphoma Myeloma and Leukemia September 2015 15 Supplement 3:e80-e81 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect